Zdrowie i gospodarka · 28/10/2014
FDA Clears DIAMOX (Acetazolamide) for Continued Approval
The FDA has determined that DIAMOX (acetazolamide) intravenous and tablets were not withdrawn from sale due to safety or effectiveness concerns. This decision allows the FDA to continue approving abbreviated new drug applications (ANDAs) for these products.